These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Thirty day all-cause mortality in patients with Escherichia coli bacteraemia in England. Abernethy JK; Johnson AP; Guy R; Hinton N; Sheridan EA; Hope RJ Clin Microbiol Infect; 2015 Mar; 21(3):251.e1-8. PubMed ID: 25698659 [TBL] [Abstract][Full Text] [Related]
26. Distribution and evolution of virulence factors in septicemic Escherichia coli. Ron EZ Int J Med Microbiol; 2010 Aug; 300(6):367-70. PubMed ID: 20510649 [TBL] [Abstract][Full Text] [Related]
27. Is Escherichia coli bacteraemia preventable? Melzer M; Welch C Lancet Infect Dis; 2012 Feb; 12(2):103-4. PubMed ID: 22281141 [No Abstract] [Full Text] [Related]
28. Time-to-positivity in patients with Escherichia coli bacteraemia. Peralta G; Roiz MP; Sánchez MB; Garrido JC; Ceballos B; Rodríguez-Lera MJ; Mateos F; De Benito I Clin Microbiol Infect; 2007 Nov; 13(11):1077-82. PubMed ID: 17727685 [TBL] [Abstract][Full Text] [Related]
29. Descriptive epidemiology of Escherichia coli bacteraemia in England, April 2012 to March 2014. Bou-Antoun S; Davies J; Guy R; Johnson AP; Sheridan EA; Hope RJ Euro Surveill; 2016 Sep; 21(35):. PubMed ID: 27608263 [TBL] [Abstract][Full Text] [Related]
32. GRAM-NEGATIVE ROD BACTEREMIA WITH A DISCUSSION OF INFECTIONS CAUSED BY HERELLEA SPECIES. MAIZTEGUI JI; KASS EH Am J Surg; 1964 May; 107():701-3. PubMed ID: 14166204 [No Abstract] [Full Text] [Related]
33. Virulence factors and phylogenetic grouping of Escherichia coli isolates from patients with bacteraemia of urinary tract origin relate to sex and hospital- vs. community-acquired origin. Skjøt-Rasmussen L; Ejrnæs K; Lundgren B; Hammerum AM; Frimodt-Møller N Int J Med Microbiol; 2012 Jul; 302(3):129-34. PubMed ID: 22571989 [TBL] [Abstract][Full Text] [Related]
34. [Escherichia coli Gomez enteritis resulting in septicemia due to the same agent]. Bol Med Hosp Infant Mex; 1954 Apr; 11(2):193-202. PubMed ID: 13181965 [No Abstract] [Full Text] [Related]
36. Preventing hospital-onset Escherichia coli bacteraemia: is hydration the solution? Francis RV; Boswell TC; Mahida N J Hosp Infect; 2019 Dec; 103(4):474-475. PubMed ID: 31260709 [No Abstract] [Full Text] [Related]
37. Comparative prevalence of virulence factors in Escherichia coli causing urinary tract infection in male infants with and without bacteremia. Bonacorsi S; Houdouin V; Mariani-Kurkdjian P; Mahjoub-Messai F; Bingen E J Clin Microbiol; 2006 Mar; 44(3):1156-8. PubMed ID: 16517919 [TBL] [Abstract][Full Text] [Related]
38. Risk factors, outcome and impact of empirical antimicrobial treatment in extended-spectrum β-lactamase-producing Escherichia coli bacteraemia. Van Aken S; Lund N; Ahl J; Odenholt I; Tham J Scand J Infect Dis; 2014 Nov; 46(11):753-62. PubMed ID: 25195648 [TBL] [Abstract][Full Text] [Related]
39. Prior use of carbapenems may be a significant risk factor for extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella spp. in patients with bacteraemia. Martínez JA; Aguilar J; Almela M; Marco F; Soriano A; López F; Balasso V; Pozo L; Mensa J J Antimicrob Chemother; 2006 Nov; 58(5):1082-5. PubMed ID: 16950822 [TBL] [Abstract][Full Text] [Related]
40. Molecular and clinical characterization of plasmid-mediated AmpC β-lactamase-producing Escherichia coli bacteraemia: a comparison with extended-spectrum β-lactamase-producing and non-resistant E. coli bacteraemia. Matsumura Y; Nagao M; Iguchi M; Yagi T; Komori T; Fujita N; Yamamoto M; Matsushima A; Takakura S; Ichiyama S Clin Microbiol Infect; 2013 Feb; 19(2):161-8. PubMed ID: 22332968 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]